2021 annual financial data

Tango Therapeutics, Inc. 2021 Net margin

Tango Therapeutics, Inc. 2021 net margin with verified reported values.

Direct answer

Net margin was -157.21%.

Operating income was -58,190,000 USD and net income was -58,235,000 USD.
Operating cash flow was -59,527,000 USD.

Get free Tango Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
37,042,000 USD
Operating income
-58,190,000 USD
Net income
-58,235,000 USD
Operating cash flow
-59,527,000 USD